Gastro-oesophageal reflux - an overview
| dc.contributor.author | Padayachee, N. | |
| dc.contributor.author | Bangalee, V. | |
| dc.contributor.author | Schellack, Natalie | |
| dc.date.accessioned | 2023-02-07T10:10:59Z | |
| dc.date.available | 2023-02-07T10:10:59Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | Gastro-oesophageal reflux disease (GORD) presents with patients experiencing discomfort due to acid-containing stomach contents persistently being refluxed into the oesophagus. This condition can lead to serious complications if left untreated. The two chief complaints of GORD are heartburn and regurgitation. The management of GORD is wide and varied and includes antacids, H2-antagonists, alginates, pro-kinetics, or proton pump inhibitors. GORD is known to cause economic and social burdens, thus appropriate management is vital to improving a patient’s quality of life. | en_US |
| dc.description.department | Pharmacology | en_US |
| dc.description.librarian | am2023 | en_US |
| dc.description.uri | http://www.sapj.co.za/index.php/sapj | en_US |
| dc.identifier.citation | Padayachee, N., Bangalee, V., Schellack, N. 2022, 'Gastro-oesophageal reflux', SA Pharmaceutical Journal, 89, no. 5, pp. 23-29. | en_US |
| dc.identifier.issn | 2221-5875 (print) | |
| dc.identifier.issn | 2220-1017 (online) | |
| dc.identifier.uri | https://repository.up.ac.za/handle/2263/89214 | |
| dc.language.iso | en | en_US |
| dc.publisher | Medpharm Publications | en_US |
| dc.rights | © Medpharm. This article is licensed under a This article is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.5 South Africa License. | en_US |
| dc.subject | Heartburn | en_US |
| dc.subject | Regurgitation | en_US |
| dc.subject | Acid suppression | en_US |
| dc.subject | Gastro-oesophageal reflux disease (GORD) | en_US |
| dc.title | Gastro-oesophageal reflux - an overview | en_US |
| dc.type | Article | en_US |